IDO1 and neoplasm: The synergistic effects of PD-L1 and IDO-1 inhibition resulted in a greater activation of tumor-infiltrating CTLs, an increase in tumor cell apoptosis and a higher survival time in treated mice, when compared with free siPD-L1 or the IDO-1 inhibitor [126].